Page last updated: 2024-08-21

arsenic trioxide and genistein

arsenic trioxide has been researched along with genistein in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Aller, P; Amrán, D; de Blas, E; Fernández, C; Sánchez, Y1
Aller, P; Calle, C; de Blas, E; Sánchez, Y1
Chen, X; Jiang, H; Krissansen, GW; Ma, Y; Pan, S; Sun, B; Sun, X1
Chen, X; Jiang, H; Liu, L; Ma, Y; Pan, S; Sun, X; Wang, J; Zhu, H1
Du, Z; Fan, Y; Hang, P; Liu, Y; Pan, Z; Wang, C; Wang, N; Zhang, Y1
Gülden, M; Klauser, E; Maser, E; Seibert, H; Seibert, S1
Dutta, S; Mahalanobish, S; Sadhukhan, P; Saha, S; Sil, PC1
Bo, P; Fu, X; Guo, S; Kuang, T; Li, L; Liu, S; Xiang, X; Xie, X; Zhang, Y1

Other Studies

8 other study(ies) available for arsenic trioxide and genistein

ArticleYear
Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
    International journal of cancer, 2008, Sep-01, Volume: 123, Issue:5

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Synergism; Electrophoretic Mobility Shift Assay; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genistein; HL-60 Cells; Humans; Immunoblotting; Jurkat Cells; Leukemia; Multienzyme Complexes; Oxidative Stress; Oxides; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Reactive Oxygen Species; U937 Cells

2008
Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
    Chemico-biological interactions, 2009, Nov-10, Volume: 182, Issue:1

    Topics: Adamantane; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Catechin; Cell Cycle; Drug Synergism; Enzyme Activation; Estradiol; Etoposide; Genistein; HL-60 Cells; Humans; Hydroquinones; Immunoblotting; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Oxides; Protein Kinase Inhibitors; Reactive Oxygen Species; RNA, Small Interfering; U937 Cells

2009
Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Cancer science, 2010, Volume: 101, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Synergism; Genistein; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Oxides; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2010
Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Cancer letters, 2011, Feb-01, Volume: 301, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Drug Synergism; Genistein; Hep G2 Cells; Humans; Liver Neoplasms; Mice; NF-kappa B; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2011
Genistein ameliorates adverse cardiac effects induced by arsenic trioxide through preventing cardiomyocytes apoptosis.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2013, Volume: 31, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium; Calcium Channels, L-Type; Caspase 3; Cells, Cultured; Down-Regulation; Electrocardiography; Genistein; Hemodynamics; JNK Mitogen-Activated Protein Kinases; Long QT Syndrome; Male; Membrane Potential, Mitochondrial; Myocytes, Cardiac; Oxides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Wistar

2013
Additivity, antagonism, and synergy in arsenic trioxide-induced growth inhibition of C6 glioma cells: effects of genistein, quercetin and buthionine-sulfoximine.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 67

    Topics: Animals; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Buthionine Sulfoximine; Cell Division; Cell Line, Tumor; Genistein; Glioma; Oxides; Quercetin; Rats

2014
Ameliorative role of genistein against age-dependent chronic arsenic toxicity in murine brains via the regulation of oxidative stress and inflammatory signaling cascades.
    The Journal of nutritional biochemistry, 2018, Volume: 55

    Topics: Age Factors; Animals; Antioxidants; Arsenic; Arsenic Poisoning; Arsenic Trioxide; Behavior, Animal; Biogenic Amines; Blood-Brain Barrier; Brain; Encephalitis; Genistein; L-Lactate Dehydrogenase; Male; Rats, Wistar; Signal Transduction; Toxicity Tests, Chronic

2018
7‑Difluoromethyl‑5,4'‑dimethoxygenistein exerts anti‑angiogenic effects on acute promyelocytic leukemia HL‑60 cells by inhibiting the TLR4/NF‑κB signaling pathway.
    Molecular medicine reports, 2020, Volume: 21, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Arsenic Trioxide; Chick Embryo; Genistein; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Toll-Like Receptor 4

2020